The objective of this study is the Synthesis of (2E, 6E)-2, 6-bis(4-nitrobenzylidene) cyclohexanone a drug against dormant version of the Mycobacterium tuberculosis H37Ra. The Cross-aldol condensation between 4-nitrobenzaldehyde and cyclopentanone catalyzed by modified fluorapatite Na/FAP catalyst in aqueous media is an important protocol for the synthesis of this product and the reaction conditions were optimized by the response surface methodology. The work-up procedure is simplified by simple filtration with high yield and by-products of usual undesirable reaction are not observed.